MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts

NEW YORK, Dec. 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts
http://www.reportlinker.com/p01921065/MediPoint-Cardiac-Assist-Devices---Global-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices


MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts

Summary

GlobalData has released its medical device report, "MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts". The report offers a comprehensive analysis of the global Cardiac Assist Device (CAD) Market, including development and sales in the Intra-Aortic Balloon Pump (IABP), Ventricular Assist Device (VAD), and Total Artificial Heart (TAH) global markets. Included within is an examination of the drivers, opportunities and barriers impacting growth of the CAD market worldwide, with an in-depth breakdown of the CAD market seven-year forecast in the US, France, Germany, Spain, Italy, UK, Japan, China and India. The report identifies and evaluates the key trends shaping the global CAD market through 2019, highlighting testimonials from top physicians around the world utilizing the devices already. Future sales expectations are discussed through careful analysis of CAD use adoption patterns in the nine major markets. The report provides insight into the competitive CAD landscape, including new companies entering the market and pipeline products in development. It quantifies the potential of long-term cardiac assist device use in end-stage heart failure patients awaiting transplantation, and examines the impact of this disruptive technology around the world. Included in the report is investigation of the highest growth sectors for CAD, with a focus on next-generation technologies due to enter the market, including transcutaneous energy transfer and fully implantable support systems.

This report was built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of cardiovascular medical device experts.

Highlights

Key Questions Answered

- First, second and third generation CAD are already on the market; however, unmet needs still exist in terms of efficiency, durability, and rates of infection. (Q).How will devices in development fulfill the unmet needs of the CAD market?
- Several companies developing CAD devices have recently received approval and others are due for approval soon. (Q).How will new entrants impact a market dominated by a few, key players?
- CAD is only recently approved for long-term use, although still only for end-stage CHF patients. (Q).How will expanded approval for use in lower-risk patients affect global revenue?
- CAD procedure volumes have been rapidly increasing in the nine major markets. (Q).What can we expect in terms of future adoption rates leading to a mature market? (Q).How will adoption increase in developing countries?

Scope

- Overview of congestive heart failure, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized cardiac assist device market revenue, annual cost of disease and CAD adoption pattern data from 2010-2012 and forecast for seven years to 2019.
- Key topics covered include strategic competitor assessment, donor availability concerns, market characterization, identification of unmet needs, reimbursement considerations, and implications for cardiac assist device market growth.
- Pipeline analysis: comprehensive data split across different stages of development, emerging trends and mechanisms of support under development, including investigation of transcutaneous energy transfer, percutaneous devices, and next-generation pumps.
- Analysis of the current and future market competition in the global Ventricular Assist Device, Intra-Aortic Balloon Pump and Total Artificial Heart markets. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Cardiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Table of Contents

1 Table of Contents 6
1.1 List of Tables 15
1.2 List of Figures 21
2 Introduction 22
2.1 Catalyst 22
3 Disease Overview - Congestive Heart Failure 24
3.1 Anatomy and Physiology 24
3.2 Pathophysiology 24
3.3 Types of Heart Failure 25
3.3.1 Classification by Progression 25
3.3.2 Classification by Location 26
3.3.3 Classification by Pumping Mechanism 26
3.4 Etiology 27
3.4.1 Conditions That Cause Heart Failure 27
3.4.2 Other Risk Factors 28
3.5 Clinical Presentation 32
3.5.1 Symptoms of Heart Failure 32
3.6 Diagnosis of Heart Failure 33
3.6.1 Stages of Heart Failure Based on Diagnosis 35
3.7 Epidemiology 37
3.7.1 Global Trends 37
3.7.2 US 37
3.7.3 France 38
3.7.4 Germany 38
3.7.5 Italy 39
3.7.6 Spain 39
3.7.7 UK 39
3.7.8 Japan 40
3.7.9 China 40
3.7.10 India 40
3.8 Epidemiology Forecast (2012-2019) 41
3.8.1 Prevalent Cases of Congestive Heart Failure 41
3.9 Clinical Outcomes 42
3.9.1 Prognosis 42
3.9.2 Surgical Risk Stratification 43
3.10 Treatment Modalities 43
3.10.1 Medication 44
3.10.2 Surgery 44
3.10.3 Cardiac Assistance 45
3.10.4 Heart Transplantation 48
3.11 Economic Impact 49
3.11.1 Individual Costs 49
3.11.2 Industry Costs 50
4 Competitive Assessment 51
4.1 Cardiac Assist Device Market, Comparison of Key Marketed Products 51
4.2 Ventricular Assist Devices Market, Key Company Share 53
4.3 Ventricular Assist Devices, Comparison based on Pump Technology 54
4.4 Ventricular Assist Devices 55
4.4.1 Overview 55
4.4.2 First-Generation Devices 56
4.4.3 Second-Generation Devices 57
4.4.4 Third-Generation Devices 57
4.4.5 Fourth-Generation Devices 58
4.4.6 Fifth-Generation Devices 58
4.4.7 Sixth-Generation Devices 58
4.4.8 Seventh-Generation Devices 58
4.4.9 Counterpulsation Devices 58
4.4.10 Adult Primary Implant Breakdown 59
4.4.11 Brand-Specific Training 59
4.5 Extracorporeal Ventricular Assist Devices 60
4.5.1 AB5000 (Abiomed, Inc.) 60
4.5.2 CentriMag, PediMag (Thoratec) 62
4.5.3 Delta-Stream DP3 Pump (Medos Medizintechnik AG) 64
4.5.4 Excor (Berlin Heart) 65
4.5.5 PVAD (Thoratec) 67
4.5.6 RotaFlow (Maquet Cardiovascular) 68
4.6 Intracorporeal Ventricular Assist Devices 70
4.6.1 DuraHeart (Terumo) 70
4.6.2 EvaHeart (Sun Medical Technology Research Corporation) 72
4.6.3 Heart Assist 5 (MicroMed Cardiovascular, Inc.) 74
4.6.4 HeartMate II (Thoratec) 76
4.6.5 HVAD (HeartWare) 80
4.6.6 Incor (Berlin Heart) 84
4.6.7 IVAD (Thoratec) 86
4.6.8 Jarvik 2000 (Jarvik Heart) 87
4.7 Percutaneous Ventricular Assist Devices 89
4.7.1 Impella (Abiomed, Inc.) 90
4.7.2 Synergy (CircuLite) 93
4.7.3 TandemHeart (Cardiac Assist, Inc.) 95
4.8 Intra-Aortic Balloon Pumps 98
4.8.1 Overview 98
4.8.2 AutoCAT 2 Wave (Teleflex) 100
4.8.3 CardioSave (Maquet Cardiovascular) 102
4.8.4 CS300 (Maquet Cardiovascular) 103
4.8.5 iVAC (PulseCath) 106
4.8.6 Xemex (Zeon) 107
4.9 Extra-Aortic Balloon Pumps 108
4.9.1 C-Pulse (Sunshine Heart) 110
4.10 Total Artificial Heart 114
4.10.1 Overview 114
4.10.2 AbioCor (Abiomed) 115
4.10.3 SynCardia (SynCardia Systems, Inc.) 117
4.11 Extracorporeal Membrane Oxygenation 119
5 Unmet Needs and Opportunities 120
5.1 Unmet Needs 120
5.1.1 Transcutaneous Energy Transfer to Reduce Risk of Infection and Improve Lifestyle 120
5.1.2 Anti-Coagulation to Reduce Risk of Stroke 122
5.1.3 Thromboresistant Coatings 123
5.1.4 Noncontact Bearing Design 124
5.2 Opportunities 124
5.2.1 Reduction of Rehospitalization Rates 124
5.2.2 NYHA Class III Patients 126
5.2.3 Destination Therapy 127
5.2.4 Pediatrics 129
5.2.5 Hybrid Combination Therapy 130
5.2.6 Mitral Valve Repair 131
6 Pipeline Products 132
6.1 Overview 132
6.2 Ventricular Assist Devices 133
6.2.1 CorAide, DexAide (Teleflex) 133
6.2.2 DuraHeart II (Terumo) 134
6.2.3 HeartMate III (Thoratec) 135
6.2.4 HeartMate X (Thoratec) 136
6.2.5 MiFlow (HeartWare) 137
6.2.6 MiTiHeart LVAD (Mohawk Innovative Technology, Inc.) 138
6.2.7 MVAD (HeartWare) 139
6.2.8 PediaFlow VAD (HeartWare) 141
6.2.9 PediPump (Cleveland Clinic) 142
6.2.10 Revolution (Vadovations, Inc.) 143
6.2.11 s.pump (Medos Medizintechnik AG) 144
6.3 Percutaneous Ventricular Assist Devices 145
6.3.1 HeartMate PHP (Thoratec) 145
6.3.2 Reitan Catheter Pump (CardioBridge GmbH) 146
6.4 Total Artificial Hearts 147
6.4.1 AbioCor II (Abiomed, Inc.) 147
6.4.2 Carmat TAH (Carmat) 148
6.4.3 Golding TAH (Cleveland Clinic) 150
6.4.4 Beatless Heart (Texas Heart Institute) 151
6.4.5 MagScrew (Cleveland Clinic) 152
6.4.6 ReinHeart (University of Aachen) 153
6.4.7 Other 154
7 Current and Future Players 155
7.1 Company Profiles 155
7.1.1 Abiomed, Inc. 155
7.1.2 Berlin Heart 157
7.1.3 CardiacAssist, Inc. 158
7.1.4 CardioBridge 159
7.1.5 Carmat 160
7.1.6 CircuLite 161
7.1.7 HeartWare International, Inc. 162
7.1.8 Jarvik Heart 164
7.1.9 Maquet Cardiovascular 166
7.1.10 Medos Medizintechnik AG 167
7.1.11 MicroMed Cardiovascular, Inc. 168
7.1.12 MiTiHeart Corporation 170
7.1.13 PulseCath BV 171
7.1.14 Sunshine Heart 172
7.1.15 SynCardia Systems, Inc. 174
7.1.16 Teleflex Medical 175
7.1.17 Terumo 176
7.1.18 Thoratec 178
7.1.19 Sun Medical 182
7.1.20 Zeon Medical 183
7.1.21 Other 184
8 Global Market Characterization 185
8.1 Cardiac Assist Device Global Revenue, 2010-2019 185
8.2 Market Revenue by Type of Device, 2012 186
9 Market Drivers, Opportunities, and Barriers 187
9.1 Market Drivers 188
9.1.1 Increasing Heart Failure Population 188
9.1.2 Technological Advancements, Miniaturizations, Leading to Increased Adoption by Physicians 189
9.1.3 Extensive Clinical Studies to Improve Adoption 189
9.1.4 Growing Patient Awareness and Increasing Numbers of Heart Centers 190
9.1.5 Aging Population to Drive Growth in Cardiac Assist Devices Market 191
9.2 Market Opportunities 192
9.2.1 Highly Under-Penetrated Market to Provide Significant Opportunity 192
9.2.2 Shortage of Donor Hearts for Transplantation Creates Opportunity 192
9.3 Market Barriers 193
9.3.1 Complications Associated with CAD 193
9.3.2 High Cost Makes Treatment Unaffordable 193
9.3.3 Alternative Therapies 194
9.3.4 Medical Device Tax Affects Manufacturers 194
9.3.5 Long Research and Development of Devices may Deter New Entrants into the Market 195
9.3.6 Complications Associated with Cardiac Assist Devices might Deter Physicians from Adoption of Their Use 195
9.4 Mergers and Acquisitions 195
9.4.1 Potential Sunshine Acquisition 195
10 Market Analysis by Segment 196
10.1 Intra-Aortic Balloon Pump: Market Characterization 196
10.1.1 IABP Global Revenue, 2010-2019 196
10.1.2 Global Revenue Breakdown by Type of Device, 2012 197
10.2 Ventricular Assist Device: Market Characterization 198
10.2.1 VAD Global Revenue, 2010-2019 198
10.2.2 Global Revenue Breakdown by Type of Device, 2012 199
10.3 Total Artificial Heart: Market Characterization 200
10.3.1 TAH Global Revenue, 2010-2019 200
10.4 Long-Term Implantation Breakdown 201
11 Country Outlook and Forecasts 202
11.1 US 202
11.1.1 Overview 202
11.1.2 Reimbursement 203
11.1.3 Affordable Care Act Rehospitalization Fees 203
11.1.4 US CAD Market Revenue, 2010-2019 204
11.2 France 205
11.2.1 Overview 205
11.2.2 France CAD Revenue, 2010-2019 206
11.3 Germany 207
11.3.1 Overview 207
11.3.2 Germany CAD Revenue, 2010-2019 209
11.4 Italy 210
11.4.1 Overview 210
11.4.2 Italy CAD Revenue, 2010-2019 210
11.5 Spain 211
11.5.1 Overview 211
11.5.2 Spain CAD Revenue, 2010-2019 212
11.6 UK 213
11.6.1 Overview 213
11.6.2 UK CAD Revenue, 2010-2019 214
11.7 Japan 215
11.7.1 Overview 215
11.7.2 Japan Market Revenue, 2010-2019 216
11.8 China 217
11.8.1 Overview 217
11.8.2 China Market Revenue, 2010-2019 217
11.9 India 219
11.9.1 Overview 219
11.9.2 India Market Revenue, 2010-2019 219
11.10 Other Countries 222
11.10.1 Brazil 222
11.10.2 The Netherlands 222
12 Appendix 223
12.1 Abbreviations 223
12.2 Bibliography 224
12.3 Methodology 237
12.3.1 Forecasting 237
12.3.2 Sources used 238
12.3.3 Forecast Assumptions and Methods 241
12.4 Coverage 244
12.5 Secondary Research 245
12.6 Forecasting Methodology 245
12.6.1 Pricing Assumptions 245
12.7 Physicians and Specialists Included in this Study 246
12.8 Primary Research 247
12.9 About the Authors 248
12.9.1 Analysts 248
12.9.2 Global Head of Healthcare 249
12.10 Definitions 249
12.11 About GlobalData 250
12.12 Contact Us 250
12.13 Disclaimer 250

1.1 List of Tables
Table 1: New York Heart Association Scale 36
Table 2: American College of Cardiology Scale 36
Table 3: Prevalent Cases of Congestive Heart Failure, All Markets, Ages ?45 Years, Men and Women (n), 2012-2019 41
Table 4: Device Strategy at Time of Implant in US, 2011 46
Table 5: Cardiac Assist Devices by Launch 51
Table 6: Ventricular Assist Devices Market, Global, Company Share ($m), 2012 53
Table 7: Cardiac Assist Devices by Type 54
Table 8: Product Profile - AB5000 60
Table 9: AB5000 SWOT Analysis, 2012 61
Table 10: Product Profile - CentriMag, PediMag 63
Table 11: CentriMag, PediMag SWOT Analysis, 2012 64
Table 12: Product Profile - Delta-Stream DP3 Pump 64
Table 13: Delta-Stream DP3 SWOT Analysis, 2012 65
Table 14: Product Profile - Excor 66
Table 15: Excor SWOT Analysis, 2012 66
Table 16: Product Profile - PVAD 67
Table 17: PVAD SWOT Analysis, 2012 68
Table 18: Product Profile - RotaFlow 68
Table 19: RotaFlow SWOT Analysis, 2012 69
Table 20: Product Profile - DuraHeart 71
Table 21: DuraHeart SWOT Analysis, 2012 72
Table 22: Product Profile - EvaHeart 72
Table 23: EvaHeart SWOT Analysis, 2012 73
Table 24: EvaHeart US Pivotal BTT Trial 73
Table 25: Product Profile - HeartAssist 5 75
Table 26: HeartAssist 5 SWOT Analysis, 2012 75
Table 27: Product Profile - HeartMate II 76
Table 28: HeartMate II SWOT Analysis, 2012 77
Table 29: REVIVE-IT 78
Table 30: ROADMAP 78
Table 31: REMATCH 79
Table 32: Product Profile - HVAD 80
Table 33: HVAD SWOT Analysis, 2012 81
Table 34: ENDURANCE 82
Table 35: ADVANCE 83
Table 36: Product Profile - Incor 84
Table 37: Incor SWOT Analysis, 2012 85
Table 38: Product Profile - IVAD 86
Table 39: IVAD SWOT Analysis, 2012 87
Table 40: Product Profile - Jarvik 2000 87
Table 41: Jarvik 2000 SWOT Analysis, 2012 88
Table 42: Jarvik 2000 US Pivotal DT Trial 89
Table 43: Product Profile - Impella 91
Table 44: Impella SWOT Analysis, 2012 92
Table 45: Product Profile - Synergy 93
Table 46: Synergy SWOT Analysis, 2012 94
Table 47: Synergy CE Mark EU Trial 94
Table 48: Product Profile - TandemHeart 95
Table 49: TandemHeart SWOT Analysis, 2012 96
Table 50: TandemHeart to Reduce Infarct Size (TRIS) 97
Table 51: Product Profile - AutoCAT 2 Wave 100
Table 52: AutoCAT 2 SWOT Analysis, 2012 101
Table 53: Product Profile - CardioSave 102
Table 54: CardioSave SWOT Analysis, 2012 103
Table 55: Product Profile - CS300 104
Table 56: CS300 SWOT Analysis, 2012 105
Table 57: Product Profile - iVAC 106
Table 58: iVAC SWOT Analysis, 2012 106
Table 59: Product Profile - Xemex 107
Table 60: Xemex SWOT Analysis, 2012 107
Table 61: Comparing Leading CAD Products 109
Table 62: Product Profile - C-Pulse 110
Table 63: C-Pulse SWOT Analysis, 2012 112
Table 64: C-Pulse US Pivotal Trial 113
Table 65: Product Profile - AbioCor 115
Table 66: AbioCor SWOT Analysis, 2012 116
Table 67: Product Profile - SynCardia 118
Table 68: SynCardia SWOT Analysis, 2012 119
Table 69: Risk Prediction Models 125
Table 70: Cardiac Assist Devices in Pipeline 132
Table 71: Product Profile - CorAide, DexAide 133
Table 72: CorAide, DexAide SWOT Analysis, 2012 134
Table 73: Product Profile - DuraHeart II 134
Table 74: DuraHeart II SWOT Analysis, 2012 134
Table 75: Product Profile - HeartMate III 135
Table 76: HeartMate III SWOT Analysis, 2012 135
Table 77: Product Profile - HeartMate X 136
Table 78: HeartMate X SWOT Analysis, 2012 136
Table 79: Product Profile - MiFlow 137
Table 80: MiFlow SWOT Analysis, 2012 137
Table 81: Product Profile - MiTiHeart Corporation 138
Table 82: MiTiHeart SWOT Analysis, 2012 139
Table 83: Product Profile - MVAD 140
Table 84: MVAD SWOT Analysis, 2012 140
Table 85: Product Profile - PediaFlow 141
Table 86: PediaFlow SWOT Analysis, 2012 141
Table 87: Product Profile - PediPump 142
Table 88: PediPump SWOT Analysis, 2012 142
Table 89: Product Profile - Revolution 143
Table 90: Revolution SWOT Analysis, 2012 143
Table 91: Product Profile - s.pump 144
Table 92: s.pump SWOT Analysis, 2012 144
Table 93: Product Profile - HeartMate PHP 145
Table 94: HeartMate PHP SWOT Analysis, 2012 145
Table 95: Product Profile - Reitan Catheter Pump 146
Table 96: Reitan Catheter Pump SWOT Analysis, 2012 147
Table 97: Product Profile - AbioCor II 147
Table 98: AbioCor II SWOT Analysis, 2012 148
Table 99: Product Profile - Carmat 149
Table 100: Carmat SWOT Analysis, 2012 149
Table 101: Product Profile - Golding TAH 150
Table 102: Golding TAH SWOT Analysis, 2012 150
Table 103: Product Profile - Beatless Heart 151
Table 104: Beatless Heart SWOT Analysis, 2012 152
Table 105: Product Profile - MagScrew 152
Table 106: MagScrew SWOT Analysis, 2012 153
Table 107: Product Profile - ReinHeart 153
Table 108: ReinHeart SWOT Analysis, 2012 154
Table 109: Company Profile - Abiomed, Inc. 155
Table 110: Abiomed SWOT Analysis, 2012 156
Table 111: Company Profile - Berlin Heart 157
Table 112: Berlin Heart SWOT Analysis, 2012 158
Table 113: Company Profile - Cardiac Assist 158
Table 114: Cardiac Assist SWOT Analysis, 2012 159
Table 115: Company Profile - CardioBridge 159
Table 116: CardioBridge SWOT Analysis, 2012 159
Table 117: Company Profile - Carmat 160
Table 118: Carmat SWOT Analysis, 2012 160
Table 119: Company Profile - CircuLite 161
Table 120: CircuLite SWOT Analysis, 2012 161
Table 121: Company Profile - HeartWare 163
Table 122: HeartWare SWOT Analysis, 2012 164
Table 123: Company Profile - Jarvik Heart 165
Table 124: Jarvik Heart SWOT Analysis, 2012 165
Table 125: Company Profile - Maquet Cardiovascular 166
Table 126: Maquet Cardiovascular SWOT Analysis, 2012 166
Table 127: Company Profile - Medos Medizintechnik AG 167
Table 128: Medos Medizintechnik AG SWOT Analysis, 2012 167
Table 129: Company Profile - MicroMed Cardiovascular, Inc. 168
Table 130: MicroMed Cardiovascular SWOT Analysis, 2012 169
Table 131: Company Profile - MiTiHeart Corporation 170
Table 132: MiTiHeart Corporation SWOT Analysis, 2012 170
Table 133: Company Profile - PulseCath 171
Table 134: PulseCath SWOT Analysis, 2012 171
Table 135: Company Profile - Sunshine Heart 172
Table 136: Sunshine Heart SWOT Analysis, 2012 173
Table 137: Company Profile - SynCardia Systems 174
Table 138: SynCardia Systems SWOT Analysis, 2012 175
Table 139: Company Profile - Teleflex 175
Table 140: Teleflex SWOT Analysis, 2012 176
Table 141: Company Profile - Terumo Heart 176
Table 142: Terumo Heart SWOT Analysis, 2012 177
Table 143: Company Profile - Thoratec 179
Table 144: Thoratec SWOT Analysis, 2012 182
Table 145: Company Profile - Sun Medical 182
Table 146: Sun Medical SWOT Analysis, 2012 183
Table 147: Company Profile - Zeon Medical 183
Table 148: Zeon Medical SWOT Analysis, 2012 184
Table 149: CAD Global Revenue by Market Type ($m), 2010-2019 185
Table 150: Heart Failure, Prevalence (% total population, n [millions]), US, 2010-2019 188
Table 151: Population Aged 65 Years and Above as Percentage of Overall Population, Global, 1960-2050 191
Table 152: Cardiac Assist Devices, Average Selling Price ($),US, 2012 194
Table 153: IABP Forecast Global Revenue ($m), 2010-2019 196
Table 154: VAD Global Revenue ($m), 2010-2019 198
Table 155: VAD Global Revenue ($m), 2010-2019 200
Table 156: US CAD Revenue ($m), 2010-2019 204
Table 157: France CAD Revenue ($m), 2010-2019 207
Table 158: Germany CAD Revenue ($m), 2010-2019 209
Table 159: Germany CAD Revenue ($m), 2010-2019 211
Table 160: Germany CAD Revenue ($m), 2010-2019 212
Table 161: UK CAD Revenue ($m), 2010-2019 214
Table 162: Japan CAD Revenue ($m), 2010-2019 217
Table 163: China CAD Revenue ($m), 2010-2019 218
Table 164: India CAD Revenue ($m), 2010-2019 221
Table 165: Sources of Epidemiological Data Used for the Forecast 238
Table 166: New York Heart Association (NYHA) Class Distributions Description 24

1.2 List of Figures
Figure 1: Classifications of Heart Failure 25
Figure 2: Stages of Heart Failure Based on Diagnosis 35
Figure 3: Treatment Modalities for Heart Failure 43
Figure 4: Ventricular Assist Devices Market, Global, Company Share (%), 2012 53
Figure 5: CAD Global Revenue by Market Type ($m), 2009-2012 185
Figure 6: Cardiac Assist Devices Market Revenue by Type of Device (%), 2012 186
Figure 7: Cardiac Assist Devices, Market Dynamics 187
Figure 8: Heart Failure, Prevalence (million), US, 2010-2019 188
Figure 9: Population Aged 65 Years and Above as Percentage of Overall Population, Global, 1960-2050 191
Figure 10: IABP Global Revenue ($m), 2010-2019 196
Figure 11: Global Market Revenue by Type of Device, 2012 197
Figure 12: VAD Global Revenue, 2010-2019 ($m) 198
Figure 13: Global Market Revenue by Type of Device, 2012 199
Figure 14: TAH Global Revenue ($m), 2010-2019 200
Figure 15: Breakdown of Long-Term Interventions by Type, 2011 201
Figure 16: US CAD Revenue ($m), 2010-2019 204
Figure 17: CAD Purchases vs. Heart Transplants, US (N), 2010-2019 205
Figure 18: France CAD Revenue ($m), 2010-2019 206
Figure 19: Germany CAD Revenue ($m), 2010-2019 209
Figure 20: Italy CAD Revenue ($m), 2010-2019 210
Figure 21: Spain CAD Revenue ($m), 2010-2019 212
Figure 22: UK CAD Revenue ($m), 2010-2019 214
Figure 23: Japan CAD Revenue ($m), 2010-2019 216
Figure 24: China CAD Revenue ($m), 2010-2019 217
Figure 25: India CAD Revenue ($m), 2010-2019 221



Companies Mentioned

Abiomed, Inc.
Berlin Heart
CardiacAssist, Inc.
CardioBridge
Carmat
CircuLite
HeartWare International, Inc.
Jarvik Heart
Maquet Cardiovascular
Medos Medizintechnik AG
MicroMed Cardiovascular, Inc.
MiTiHeart Corporation
PulseCath BV
Sunshine Heart
SynCardia Systems, Inc.
Teleflex Medical
Terumo
Thoratec
Sun Medical
Zeon Medical


To order this report: MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts
http://www.reportlinker.com/p01921065/MediPoint-Cardiac-Assist-Devices---Global-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.